Plant-based natural products for symptomatic relief of Parkinson's disease: prevalence, interest, awareness and determinants
Diadhiou, S.; Maas, B. R.; Schootemeijer, S.; Bloem, B. R.; de Vries, N. M.; Calon, F.; Darweesh, S. K. L.; de Rus Jacquet, A.
Show abstract
Natural health products (NHP) have emerged as a potential symptomatic therapeutic approach for persons with Parkinsons disease (PwP). The objective of this study was to quantify the prevalence of ever use of NHP, interest in plant-based NHP, awareness of potential herb-drug interactions, and how often NHP use was discussed by PwP with their healthcare professionals. We addressed these objectives by embedding a cross-sectional 4-item survey within a large population-based cohort of PwP (PRIME-NL study). Sixty-five percent (n=367) of the 566 participants who were contacted completed the survey. Of those participants, 132 (36%) reported having used NHP to alleviate Parkinsons disease (PD)-related symptoms, with coffee, cannabis and turmeric being the most popular. Overall, 12% (n=44) of PwP had used at least one NHP other than coffee or cannabis. Furthermore, 71% (n=259) participants expressed an interest in exploring the use of NHP, but only 39% (n=51) of NHP users were aware that these products could interact with PD medication. Finally, only 39% (n=51) of NHP users had discussed the use of NHP with their neurologist or PD nurse specialist. In a sensitivity analysis, we conservatively assumed that all non-responders to the survey had never used NHP and had no interest in exploring NHP. This rendered an estimated prevalence of NHP use of 23% and an estimated interest in exploring NHP of 46%. In conclusion, over one in three PwP has used NHP to alleviate symptoms of PD and the majority of PwP is interested in exploring the use of plant-based NHP. Most users had not discussed the intake of NHP with their PD healthcare professional and were unaware that these products could interact with PD medication. This study supports the need for evidence-based research on the properties of plant-derived therapeutics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AccessPD - a ‘next generation’ registry to accelerate Parkinson’s disease research 95%
- Disease progression strikingly differs in research and real-world Parkinson's populations 94%
- Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK Biobank 93%
Similar papers in this journal
- A Pilot Interventional Study on Feasibility and Effectiveness of the CUE1 device in Parkinson’s disease 93%
- Timely referral for advanced therapy in Parkinson’s disease. Development of a screening tool 93%
- Effect of Eight-Week Online Cognitive Training in Parkinson’s Disease: A Randomized Controlled Trial 92%
Similar papers in this journal
- Parkinson's disease psychosis associated with accelerated multi-domain cognitive decline 91%
- Decline in striatal binding ratio associated with accelerated decline in performance on Symbol Digit Modality but not MoCA in Parkinson’s disease psychosis 90%
- Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study 88%
Similar papers in this journal
- Retrospective Case-Control Study of Pre-Diagnosis Observational and Prescription Data in Parkinson's Disease 94%
- Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2 93%
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.